AEterna Zentaris Participating on Oncology Panel at Upcoming RBC Capital Markets Healthcare Conference in New York
December 11 2006 - 7:30AM
PR Newswire (US)
QUEBEC CITY, QC, Dec. 11 /PRNewswire-FirstCall/ -- AEterna Zentaris
Inc. (TSX: AEZ; Nasdaq: AEZS) today announced that its Executive
Vice President, Global R&D and COO, Dr. Jurgen Engel, will be a
participant on the Cancer Horoscope: Future Treatments panel on
Thursday, December 14, 2006 at 10:00 a.m. Eastern, as part of the
2006 RBC Capital Markets Healthcare Conference which will be held
at the Westin New York at Times Square Hotel in New York City. A
live webcast of this presentation will be available on AEterna
Zentaris' website at http://www.aeternazentaris.com/ in the
Investors section. A replay will also be available for a period of
30 days. About AEterna Zentaris Inc. AEterna Zentaris Inc. is a
growing global biopharmaceutical company focused on endocrine
therapy and oncology, with proven expertise in drug discovery,
development and commercialization. News releases and additional
information are available at http://www.aeternazentaris.com/.
DATASOURCE: AETERNA ZENTARIS INC. CONTACT: Media Relations: Paul
Burroughs, (418) 652-8525, ext. 406, ; Investor Relations: Jenene
Thomas, (418) 655-6420, (908) 996-3154,
Copyright